Skip to main content
TipRanks
Go Ultimate75% OFF

eFFECTOR Therapeutics (EFTR) Q4 2022 Earnings Report

264 Followers

EFTR Q4 2022 EPS Results

Actual EPS
-$5.50
Consensus EPS
-$5.95
Beat/Miss
Beat by +$0.45
One Year Ago EPS
$11.00

EFTR Q4 2022 Revenue Results

Actual Revenue
$675.00K
Expected Revenue
$664.00K
Beat/Miss
Beat by +$11.00K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2022
Date
03/08/2023
Time
After Close
Conference Call
Wednesday, March 8, 2023

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

EFTR Earnings History

EFTR earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 13, 20252025 (Q1)―--2.16―
Mar 12, 20252024 (Q4)―-――
Nov 04, 20242024 (Q3)―-――
Aug 06, 20242024 (Q2)-2.02--4.25―
May 09, 20242024 (Q1)-2.17-2.16-664.00% (+3.84)
Mar 25, 20242023 (Q4)-2.82-3.42-5.537.82% (+2.08)
Nov 13, 20232023 (Q3)-3.08-3.25-5.7543.48% (+2.50)
Aug 08, 20232023 (Q2)-4.95-4.25-4.250.00% (+0.00)
May 09, 20232023 (Q1)-5.08-6.001.75-442.86% (-7.75)
Mar 08, 20232022 (Q4)-5.95-5.5011-150.00% (-16.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed